Work

Efficacy and safety of sunvozertinib in treatment naïve NSCLC patients with EGFR exon20 insertion mutations.

Year: 2023

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2023.41.16_suppl.9073

Authors: Yan Xu, James Chih-Hsin Yang, Chao-Hua Chiu, Ping-Chih Hsu, Paul Mitchell, Chia lun Chang, Tom John, Lyudmila Bazhenova, Tae Min Kim, Ching Wan Yip, Mengzhao Wang, Pasi A. Janne, Caicun Zhou

Institutions: Chinese Academy of Medical Sciences & Peking Union Medical College, Peking Union Medical College Hospital, National Taiwan University Hospital, Taipei Veterans General Hospital, Chang Gung University, Linkou Chang Gung Memorial Hospital, Austin Hospital, Wan Fang Hospital, Peter MacCallum Cancer Centre, University of California San Diego, Moores Cancer Center, Seoul National University Hospital, Dizal (Jiangsu) Pharmaceutical Co., Ltd. (China), Dana-Farber Cancer Institute, Tongji University, Shanghai Pulmonary Hospital

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4379280998

Cites:

Cited by: 15

Related to: 10